Skip to main content

Table 4 Comparison between cancer/no cancer patients and demographic/clinical characteristics

From: Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study

Criteria

Cancer

p-value

Yes (n = 18)

No (n = 49)

Age at CVID onset; median (min–max)

29 (10–75)

30 (10–75)

0.769

Age at CVID diagnosis; median (min–max)

52 (20–79)

46 (16–78)

0.449

Autoimmunity: Yes (n)

11

19

0.103

ITP: Yes (n)

5

7

0.202

Granulomatosis: Yes (n)

3

9

0.872

CVID-associated enteropathy: Yes (n)

2

9

0.477

  1. CVID: Common variable immunodeficiency; ITP: Immune thrombocytopenic purpura; CVID onset was defined as the occurrence of the first findings related to CVID (see “Patients and methods” for details)